Ataluren
Product Specifications
CAS Number
775304-57-9
Target
Autophagy, CFTR
Related Pathways
Membrane transporter/Ion channel, Autophagy
Purity
0.9984
Bioactivity
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk.
Smiles
FC1=C(C2=NC(=NO2)C3=CC(C(O)=O)=CC=C3)C=CC=C1
Molecular Formula
C15H9FN2O3
Molecular Weight
284.24
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6375599-01 0.1 mL
Cystatin C (Cystatin-C, Cystatin-3, Gamma-trace, Neuroendocrine Basic Polypeptide, Post-gamma-globulin, CST3) (PE)
Sign In for Pricing
View Details MBS6375599-02 5x 0.1 mL
Cystatin C (Cystatin-C, Cystatin-3, Gamma-trace, Neuroendocrine Basic Polypeptide, Post-gamma-globulin, CST3) (PE)
Sign In for Pricing
View Details MBS1164235-01 0.02 mg (E-Coli)
Recombinant Clostridium beijerinckii Adenylosuccinate synthetase (purA)
Sign In for Pricing
View Details MBS1164235-02 0.02 mg (Yeast)
Recombinant Clostridium beijerinckii Adenylosuccinate synthetase (purA)
Sign In for Pricing
View Details MBS1164235-03 0.1 mg (E-Coli)
Recombinant Clostridium beijerinckii Adenylosuccinate synthetase (purA)
Sign In for Pricing
View Details MBS1164235-04 0.1 mg (Yeast)
Recombinant Clostridium beijerinckii Adenylosuccinate synthetase (purA)
Sign In for Pricing
View Details